- Home
- NCLH vs ASND Comparison
NCLH vs ASND Comparison
Compare NCLH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCLH | ASND |
|---|---|---|
| Founded | 1966 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 12.2B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NCLH | ASND |
|---|---|---|
| Price | $22.72 | $208.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 15 |
| Target Price | $28.11 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 17.1M | 778.0K |
| Earning Date | 11-04-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $9,692,558,000.00 | $758,592,045.00 |
| Revenue This Year | $6.85 | $98.90 |
| Revenue Next Year | $10.76 | $83.74 |
| P/E Ratio | $16.58 | ★ N/A |
| Revenue Growth | 3.59 | ★ 97.46 |
| 52 Week Low | $14.21 | $118.03 |
| 52 Week High | $29.29 | $229.94 |
Technical Indicators
Market Signals| Indicator | NCLH | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 63.64 | 51.91 |
| Support Level | $21.51 | $197.16 |
| Resistance Level | $24.32 | $216.19 |
| Average True Range (ATR) | 0.87 | 9.92 |
| MACD | 0.38 | 0.24 |
| Stochastic Oscillator | 73.49 | 45.57 |
Price Performance
Historical ComparisonAbout NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.